We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

Olives and olive oil.

Extra Virgin Olive Oil Slows Memory Decline in Down Syndrome Mouse Model

The structure of a protein.

AlphaFold Wins the Nobel Prize in Chemistry 2024

A woman jogging.

How Last Week’s Workout or Restless Night Still Affects Your Brain

Gene Therapy Shows Long-Term Benefit for Rare Pediatric Brain Disease

Male Dragonflies Are Evolving To Cope With Their Hot Black Wings

Your Hot Sauce Expectations Affect How Spicy a Dip Tastes

News

Lentigen and Evrogen Enter License Agreement

Lentigen will obtain access to certain fluorescent protein technologies from Evrogen.

CytRx Accelerates RNAi Therapeutics Programs

CytRx plans to form a new subsidiary to accelerate the development and commercialization RNAi based drugs.

Clinical Data Initiates Phase III Trial for Antidepressant 'Vilazodone'

The outcome of this trial would serve as one of two pivotal trials required for a new drug application.

Cellomics and Evotec Sign License Agreement

Companies to collaborate on cell-biology solutions for life-science markets.

Viral, Gold Nanoparticles Can Assemble Themselves to Find and Treat Disease

The study defines how assembled particles of gold could possibly be "tuned" to destroy tissue.

SuperGen Acquires Montigen Pharmaceuticals

SuperGen will pay the Montigen stockholders a total of $18.0 million upon the closing of the transaction.

Stratagene Posts $21-Million Bond to Secure Damages Awarded to Third Wave

The jury has found Stratagene liable for willful patent infringement.

Researchers Uncovered Secrets of the "Nanoworld"

Scientists determine the structure of a type of gold-palladium nanoparticle.

NCBI Adopts Standard for Accepting 454's Sequencing Data

First sequence trace format adopted by NCBI since Sanger method.

Nanomedicine Center to Help Develop Cancer and CNS Therapies

The University of Maryland and Rexahn Pharmaceuticals are working together to help develop cancer-fighting drugs and central nervous system therapies.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter